LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
SGR/Legislative Action –
New Legislation –
ACA Oversight –
High-Risk Pools – On March 14, CMS announced that it will further extend Pre-Existing Condition Insurance Plan (PCIP) coverage through April 30 for individuals who have not enrolled in an Exchange plan. More information: http://bit.ly/NQBvTr
MedPAC – On March 14, MedPAC released its March 2014 report to Congress on Medicare payment policy. Press release: http://1.usa.gov/1donyZb Fact sheet: http://1.usa.gov/1j0mnPJ Report: http://1.usa.gov/1jbrJKn
Medicare Advantage –
Health IT –
ACA Legal Challenges – On March 25, the Supreme Court heard oral arguments in two cases challenging the legality of the ACA’s contraception coverage requirements, Sebelius v. Hobby Lobby Stores and Conestoga Wood Specialties v. Sebelius. Meanwhile, the U.S. Court of Appeals for the District of Columbia heard oral arguments in a case challenging the legality of premium subsidies for individuals purchasing insurance through federal Exchanges, Halbig v. Sebelius.
For more information, contact Mary Langowski (202.799.4362 or email@example.com), Niki Carelli (202.799.4367 or firstname.lastname@example.org) or Kristen Ratcliff (202.799.4715 or email@example.com).
Published by DLA Piper LLP (US) Copyright © 2014 DLA Piper LLP (US) All Rights Reserved This bulletin is intended as a general overview and discussion of the subjects dealt with. It is not intended, and should not be used, as a substitute for taking legal advice in any specific situation. DLA Piper will accept no responsibility for any actions taken or not taken on the basis of this publication. Pursuant to applicable Rules of Professional Conduct, it may constitute advertising. Circular 230 Notice: In compliance with US Treasury Regulations, please be advised that any tax advice given herein (or in any attachment) was not intended or written to be used, and cannot be used, for the purpose of (i) avoiding tax penalties or (ii) promoting, marketing or recommending to another person any transaction or matter addressed herein. You are receiving this communication because you are a valued client or friend of DLA Piper. DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to www.dlapiper.com. All rights reserved. To unsubscribe from DLA Piper mailing lists, reply to this message with REMOVE in the subject line.
For more information about LexisNexis products and solutions, connect with us through our corporate site.